<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PENICILLIN V POTASSIUM- penicillin v potassiumÂ tabletÂ </strong><br>Lake Erie Medical DBA Quality Care Products LLC<br></p></div>
<h1>
<span class="Bold">Penicillin V Potassium Tablets, USP</span> - <span class="Bold">250 mg and 500 mg </span><br><span class="Bold">Penicillin V Potassium for Oral Solution, USP - 125 mg/5 mL and 250 mg/5 mL</span><br><span class="Bold">R<span class="Sub">x</span> Only</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f59d8df3-5f69-4e27-bdab-b3de92dbe5b2"></a><a name="section-1"></a><p></p>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Penicillin V Potassium Tablets, Penicillin V Potassium for Oral Solution and other antibacterial drugs, Penicillin V Potassium Tablets and Penicillin V Potassium for Oral Solution should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_58ee2449-ed4e-455b-a8e9-566fcc8f2763"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Penicillin V is the phenoxymethyl analog of penicillin G. Penicillin V potassium is the potassium salt of penicillin V. Penicillin V Potassium is designated chemically as 4-Thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo- 6-[(phenoxyacetyl)amino]-, monopotassium salt, [2S-(2Î±,5Î±,6Î²)]-. It has the following chemical structure:</p>
<div class="Figure"><img alt="Penicillin V  Potassium  Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e3b6a3b4-a61a-4432-9e90-c1ba9e210939&amp;name=0168e983-9624-4d6a-a774-c3419e86aa69-01.jpg"></div>
<p>The molecular formula is C<span class="Sub">16</span>H<span class="Sub">17</span>KN<span class="Sub">2</span>O<span class="Sub">5</span>S, and the molecular weight is 388.48.</p>
<p>Each tablet contains Penicillin V Potassium equivalent to 250 mg or 500 mg (400,000 or 800,000 units) of penicillin V.</p>
<p>Each Penicillin V Potassium tablet, USP, 250 mg contains 0.73 mEq (28.2 mg) of Potassium and each Penicillin V potassium tablet, USP, 500 mg contains 1.46 mEq (56.4 mg) of Potassium.</p>
<p>Each tablet also contains the following inactive ingredients: lactose, NF; magnesium stearate, NF; microcrystalline cellulose, NF; polyethylene glycol, NF; povidone, USP; sodium laurel sulfate, NF.</p>
<p>Each 5 mL when reconstituted as directed contains Penicillin V Potassium equivalent to 125 mg or 250 mg (200,000 or 400,000 units) of Penicillin V.</p>
<p>Each 5 mL of reconstituted Penicillin V Potassium for Oral Solution, USP, 125 mg per 5 mL contains 0.42 mEq (16.4 mg) of Potassium. Each 5 mL of reconstituted Penicillin V Potassium for Oral Solution, USP, 250 mg per 5 mL contains 0.85 mEq (32.8 mg) of Potassium.</p>
<p>Each 5 mL of reconstituted suspension also contains the following inactive ingredients: aspartame, NF; citric acid, USP; FD&amp;C Red No. 40; flavors; primary taste modifier; saccharin sodium, USP; silicon dioxide, NF; sodium citrate, USP; sodium propionate, NF; sucrose, NF.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_520fa77a-6584-4ddd-8c29-64157e6c3159"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Penicillin V exerts a bactericidal action against penicillin-sensitive microorganisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell-wall mucopeptide. It is not active against the penicillinase-producing bacteria, which include many <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of staphylococci.  The drug exerts high <span class="Italics">in vitro</span> activity against staphylococci (except penicillinase-producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>), streptococci (groups A, C, G, H, L and M) and pneumococci.  Other organisms sensitive <span class="Italics">in vitro</span> to penicillin V are <span class="Italics">Corynebacterium diphtheriae, Bacillus anthracis, </span>Clostridia,<span class="Italics"> Actinomyces bovis, Streptobacillus moniliformis, Listeria monocytogenes, </span>Leptospira and<span class="Italics"> Neisseria gonorrhoeae. Treponema pallidum </span>is extremely sensitive.</p>
<p>The potassium salt of penicillin V has the distinct advantage over penicillin G in resistance to inactivation by gastric acid. It may be given with meals; however, blood levels are slightly higher when the drug is given on an empty stomach. Average blood levels are two to five times higher than the levels following the same dose of oral penicillin G and also show much less individual variation.</p>
<p>Once absorbed, penicillin V is about 80% bound to serum protein. Tissue levels are highest in the kidneys, with lesser amounts in the liver, skin, and intestines. Small amounts are found in all other body tissues and cerebrospinal fluid. The drug is excreted as rapidly as it is absorbed in individuals with normal kidney function; however, recovery of the drug from the urine indicates that only about 25% of the dose given is absorbed. In neonates, young infants, and individuals with impaired kidney function, excretion is considerably delayed.</p>
<div class="Section" data-sectionCode="49489-8">
<a name="ID_4ab24086-d90a-4f36-8ddd-e5241f40b2fc"></a><a name="section-3.1"></a><p></p>
<h2>Microbiology:</h2>
<p class="First"><span class="Bold"><span class="Underline">Susceptibility Testing</span></span></p>
<p><span class="Italics">Diffusion Techniques</span></p>
<p>Quantitative methods that require measurement of zone diameters provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure<span class="Sup">2,4 </span>which has been recommended for use with disks to test susceptibility of organisms to penicillin uses the 10 unit (U) penicillin disk. Interpretation involves the correlation of the diameters obtained in the disk test with the <span class="product-label-link" type="condition" conceptid="4190299" conceptname="Broth microdilution susceptibility test">minimum inhibitory concentration</span> (MIC) for penicillin.</p>
<p>Reports from the laboratory providing results of the standard single-disk susceptibility test with a 10 U penicillin disk should be interpreted according to the criteria provided in <a href="#_Ref386033107">Table 1</a>.<br><br><span class="Italics">Dilution Techniques</span></p>
<p>Quantitative methods that are used to determine <span class="product-label-link" type="condition" conceptid="4190299" conceptname="Broth microdilution susceptibility test">minimum inhibitory concentrations</span> (MICs) provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure<span class="Sup">3,4 </span>uses a standardized dilution method (broth or agar) or equivalent with penicillin powder. The MIC values obtained should be interpreted according to the criteria provided in <a href="#_Ref386033107">Table 1</a>.</p>
<a name="_Ref386033107"></a><table>
<caption><span>Table 1: SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA</span></caption>
<colgroup>
<col width="40%">
<col width="8%">
<col width="8%">
<col width="8%">
<col width="9%">
<col width="9%">
<col width="9%">
</colgroup>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="middle"><p class="First"><span class="Bold">Pathogen</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Susceptibility Test Result Interpretive Criteria</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Disk diffusion (Zone diameter in mm)</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Minimal Inhibitory Concentration (MIC in mcg/mL)</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">S</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">I</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">R</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">S</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">I</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">R</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Italics">Staphylococcus </span>spp.</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&gt;</span>29</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&lt;</span>28</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&lt;</span>0.12</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&gt;</span>0.25</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Italics">Streptococcus </span>spp. (beta-hemolytic group)</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&gt;</span>24</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&lt;</span>0.12</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">-</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First"><span class="Italics">Streptococcus pneumoniae</span> (non-<span class="product-label-link" type="condition" conceptid="435785" conceptname="Meningitis">meningitis</span> isolates)</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="middle"></td>
<td class="Botrule Lrule Rrule Toprule" valign="middle"></td>
<td class="Botrule Lrule Rrule Toprule" valign="middle"></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&lt;</span>0.06</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">0.12-1</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Underline">&gt;</span>2</p></td>
</tr>
</tbody>
</table>
<p>A report of â€œsusceptibleâ€? (S) indicates that the pathogen is likely to be inhibited by usually achievable concentrations of the antimicrobial compound in the blood. A report of â€œintermediateâ€? (I) indicates that the result should be considered equivocal, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of the drug can be used. This category also provides a buffer zone that prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of â€œresistantâ€? (R) indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.<br><br><span class="Italics">Quality Control</span></p>
<p>Standardized susceptibility test procedures require the use of laboratory control microorganisms<span class="Sup">2,3,4</span>. The 10 U penicillin disk and the standard penicillin powder should provide respectively the following zone diameters and MIC values in these quality laboratory test control <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>:</p>
<table>
<caption><span>Table 2: ACCEPTABLE QUALITY CONTROL RANGES</span></caption>
<colgroup>
<col width="31%">
<col width="31%">
<col width="31%">
</colgroup>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="middle"><p class="First"><span class="Bold">Microorganism</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Acceptable Quality Control Ranges</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Disk diffusion (Zone diameter ranges in mm)</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First"><span class="Bold">Minimal Inhibitory Concentration Range (MIC in mcg/mL)</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Italics">Staphylococcus aureus </span>ATCC 25923</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">26-37</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="middle"></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Italics">Staphylococcus aureus </span>ATCC 29213</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="middle"></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">0.25-2</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First"><span class="Italics">Streptococcus <span class="product-label-link" type="condition" conceptid="255848" conceptname="Pneumonia">pneumonia</span></span> ATCC 49619</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">24-30</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">0.25-1</p></td>
</tr>
</tbody>
</table>
<p></p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_16394f09-6f4d-405f-8cac-9349a7b4663e"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Penicillin V Potassium Tablets, USP and Penicillin V Potassium for Oral Solution, USP, are indicated in the treatment of mild to moderately severe <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to penicillin G- sensitive microorganisms. Therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response.</p>
<p>NOTE: Severe <span class="product-label-link" type="condition" conceptid="255848" conceptname="Pneumonia">pneumonia</span>, <span class="product-label-link" type="condition" conceptid="4209859" conceptname="Empyema">empyema</span>, <span class="product-label-link" type="condition" conceptid="132736" conceptname="Bacteremia">bacteremia</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>, <span class="product-label-link" type="condition" conceptid="435785" conceptname="Meningitis">meningitis</span>, and <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span> should not be treated with penicillin V during the acute stage. Indicated surgical procedures should be performed.</p>
<p>The following <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> will usually respond to adequate dosage of Penicillin V:</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="437779" conceptname="Streptococcal infectious disease">Streptococcal infections</span></span> (without <span class="product-label-link" type="condition" conceptid="132736" conceptname="Bacteremia">bacteremia</span>): <br>Mild-to-moderate <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the upper respiratory tract, scarlet <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and mild <span class="product-label-link" type="condition" conceptid="138346" conceptname="Erysipelas">erysipelas</span>.</p>
<p>NOTE: Streptococci in groups A, C, G, H, L, and M are very sensitive to penicillin. Other groups, including group D (enterococcus) are resistant.</p>
<p><span class="Italics">Pneumococcal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span></span>: <br>Mild to moderately severe <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the respiratory tract.</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">Staphylococcal infections</span></span> - penicillin G sensitive: <br>Mild <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the skin and soft tissues.</p>
<p>NOTE: Reports indicate an increasing number of <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of staphylococci resistant to penicillin G, emphasizing the need for culture and sensitivity studies in treating suspected <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span>.</p>
<p><span class="Italics">Fusospirochetosis</span> (Vincent's <span class="product-label-link" type="condition" conceptid="4281516" conceptname="Gingivitis">gingivitis</span> and <span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">pharyngitis</span>): <br>Mild to moderately severe <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the oropharynx usually respond to therapy with oral penicillin.</p>
<p>NOTE: Necessary dental care should be accomplished in <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> involving the gum tissue.</p>
<p>Medical conditions in which oral penicillin therapy is indicated as prophylaxis: For the prevention of recurrence following <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span> and/or <span class="product-label-link" type="condition" conceptid="440990" conceptname="Chorea">chorea</span>: Prophylaxis with oral penicillin on a continuing basis has proven effective in preventing recurrence of these conditions.</p>
<p>Although no controlled clinical efficacy studies have been conducted, penicillin V has been suggested by the American Heart Association and the American Dental Association for use as an oral regimen for prophylaxis against <span class="product-label-link" type="condition" conceptid="4116649" conceptname="Bacterial endocarditis">bacterial endocarditis</span> in patients who have congenital heart disease or rheumatic or other acquired <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">valvular heart disease</span> when they undergo dental procedures and surgical procedures of the upper respiratory tract.<span class="Sup">1</span> Oral penicillin should not be used in those patients at particularly high risk for <span class="product-label-link" type="condition" conceptid="441589" conceptname="Endocarditis">endocarditis</span> (e.g. those with prosthetic heart valves or surgically constructed systemic pulmonary shunts). Penicillin V should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower-intestinal tract surgery, sigmoidoscopy, and childbirth. Since it may happen that <span class="Italics">alpha</span> haemolytic streptococci relatively resistant to penicillin may be found when patients are receiving continuous oral penicillin for secondary prevention of <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span>, <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> agents, other than penicillin may be chosen for these patients and prescribed in addition to their continuous <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span> <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> regimen.</p>
<p>NOTE: When selecting antibiotics for the prevention of <span class="product-label-link" type="condition" conceptid="4116649" conceptname="Bacterial endocarditis">bacterial endocarditis</span>, the physician or dentist should read the full joint statement of the American Heart Association and the American Dental Association.<span class="Sup">1</span></p>
<p>To reduce the development of drug-resistant bacteria and maintain the effectiveness of Penicillin V Potassium Tablets, Penicillin V Potassium for Oral Solution and other antibacterial drugs, Penicillin V Potassium Tablets, and Penicillin V Potassium for Oral Solution should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_555766e4-d073-4040-8fc4-80ed742b2e27"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">A previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> to any penicillin is a contraindication.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_89dba8bf-de93-411e-82b3-552bd5a6f2f5"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">SERIOUS AND OCCASIONALLY FATAL <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY</span> (anaphylactic) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY.  THESE REACTIONS ARE MORE LIKELY TO OCCUR IN INDIVIDUALS WITH A HISTORY OF PENICILLIN <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY</span> AND/OR A HISTORY OF SENSITIVITY TO MULTIPLE ALLERGENS.  THERE HAVE BEEN REPORTS OF INDIVIDUALS WITH A HISTORY OF PENICILLIN <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY</span> WHO HAVE EXPERIENCED SEVERE REACTIONS WHEN TREATED WITH CEPHALOSPORINS.  BEFORE INITIATING THERAPY WITH PENICILLIN V POTASSIUM, CAREFUL INQUIRY SHOULD BE MADE CONCERNING PREVIOUS <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY REACTIONS</span> TO PENICILLINS, CEPHALOSPORINS, OR OTHER ALLERGENS.  IF AN <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">ALLERGIC REACTION</span> OCCURS, PENICILLIN V POTASSIUM SHOULD BE DISCONTINUED AND APPROPRIATE THERAPY INSTITUTED.  <span class="Bold">SERIOUS <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">ANAPHYLACTIC REACTIONS</span> REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE.  OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED.</span></p>
<p><span class="Italics">Clostridium difficile</span> associated <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> (CDAD) has been reported with use of nearly all antibacterial agents, including Penicillin V Potassium Tablets and Penicillin V Potassium for Oral Solution, and may range in severity from mild <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> to fatal <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>.  Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <span class="Italics">C. difficile.</span></p>
<p><span class="Italics">C. difficile </span>produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">C. difficile </span>cause increased morbidity and mortality, as these <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> can be refractory to antimicrobial therapy and may require colectomy.  CDAD must be considered in all patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> following antibiotic use.  Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p>
<p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against <span class="Italics">C. difficile</span> may need to be discontinued.  Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of <span class="Italics">C. difficile</span>, and surgical evaluation should be instituted as clinically indicated.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_63b9754b-c31e-4ce5-b7ab-a9ea6569a041"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Penicillin should be used with caution in individuals with histories of significant allergies and/or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>.</p>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_61871f1e-ee3a-4ecb-80cb-862ee4034f43"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Prescribing Penicillin V Potassium Tablets and Penicillin V Potassium for Oral Solution in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p>
<p>The oral route of administration should not be relied upon in patients with severe illness, or with <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="195301" conceptname="Acute dilatation of stomach">gastric dilatation</span>, <span class="product-label-link" type="condition" conceptid="318186" conceptname="Achalasia of esophagus">cardiospasm</span> or <span class="product-label-link" type="condition" conceptid="4010029" conceptname="Increased intestinal motility">intestinal hypermotility</span>.</p>
<p>Occasionally patients will not absorb therapeutic amounts of orally administered penicillin.</p>
<p>In <span class="product-label-link" type="condition" conceptid="437779" conceptname="Streptococcal infectious disease">streptococcal infections</span>, therapy must be sufficient to eliminate the organism (ten-day minimum): otherwise the sequelae of streptococcal disease may occur. Cultures should be taken following completion of treatment to determine whether streptococci have been eradicated.</p>
<p>Prolonged use of antibiotics may promote the overgrowth of nonsusceptible organisms, including fungi. Should <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occur, appropriate measures should be taken.</p>
<p>Oral Solutions contain aspartame. Phenylketonurics: Both the 125 mg and 250 mg Oral Solutions contain phenylalanine 4.5 mg per 5 mL.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_857ff728-45bb-4a50-a8a8-e09c27644527"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be counseled that antibacterial drugs, including Penicillin V Potassium Tablets and Penicillin V Potassium for Oral Solution should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>. They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g. the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>).</p>
<p>When Penicillin V Potassium Tablets or Penicilin V Potassium Oral Solution are prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may:</p>
<p>(i) Decrease the effectiveness of the immediate treatment, and<br>(ii) Increase the likelihood that bacteria will develop resistance and will not be treatable by penicillin-VK or other antibacterial drugs in the future.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued.  Sometimes after starting treatment with antibiotics, patients can develop watery and <span class="product-label-link" type="condition" conceptid="443530" conceptname="Hematochezia">bloody stools</span> (with or without <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach cramps</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>) even as late as two or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_684ff57f-d697-48ec-a81a-84bd03dbdd69"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Although the incidence of reactions to oral penicillins has been reported with much less frequency than following parenteral therapy, it should be remembered that all degrees of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, including fatal <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, have been reported with oral penicillin.</p>
<p>The most common reactions to oral penicillin are <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, and <span class="product-label-link" type="condition" conceptid="4217621" conceptname="Black hairy tongue">black hairy tongue</span>. The <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> reported are <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin eruptions</span> (maculopapular to <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>), <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and other serum-sicknesslike reactions, <span class="product-label-link" type="condition" conceptid="22350" conceptname="Edema of larynx">laryngeal edema</span> and <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span> and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> may frequently be the only reaction observed. <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">Hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span> and <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">nephropathy</span> are infrequent reactions and usually associated with high doses of parenteral penicillin.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_6e70d88f-0468-44c7-92a9-1f409bbcf94f"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The dosage of penicillin V potassium tablets and penicillin V potassium for oral solution should be determined according to the sensitivity of the causative microorganisms and the severity of the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, and adjusted to the clinical response of the patient.</p>
<p>The usual dosage recommendations for adults and children 12 years and over are as follows:</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="437779" conceptname="Streptococcal infectious disease">Streptococcal infections</span></span><br>Mild to moderately severe - of the upper respiratory tract and including scarlet <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and <span class="product-label-link" type="condition" conceptid="138346" conceptname="Erysipelas">erysipelas</span>: 125 mg to 250 mg (200,000 to 400,000 units) every 6 to 8 hours for 10 days.</p>
<p><span class="Italics">Pneumococcal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span></span><br>Mild to moderately severe - of the respiratory tract, including <span class="product-label-link" type="condition" conceptid="372328" conceptname="Otitis media">otitis media</span>: 250 mg to 500 mg (400,000 to 800,000 units) every 6 hours until the patient has been afebrile for at least 2 days.</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">Staphylococcal infections</span></span><br>Mild <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of skin and soft tissue (culture and sensitivity tests should be performed): 250 mg to 500 mg (400,000 to 800,000 units) every 6 to 8 hours.</p>
<p><span class="Italics">Fusospirochetosis</span> (Vincent's <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>) <br>of the oropharynx. Mild to moderately severe <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>: 250 mg to 500 mg (400,000 to 800,000 units) every 6 to 8 hours.</p>
<p>For the prevention of recurrence following <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span> and/or <span class="product-label-link" type="condition" conceptid="440990" conceptname="Chorea">chorea</span>: 125 mg to 250 mg (200,000 to 400,000 units) twice daily on a continuing basis.</p>
<p>For prophylaxis against <span class="product-label-link" type="condition" conceptid="4116649" conceptname="Bacterial endocarditis">bacterial endocarditis</span><span class="Sup">1</span> in patients with congenital heart disease or rheumatic or other acquired <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">valvular heart disease</span> when undergoing dental procedures or surgical procedures of the upper respiratory tract: 2 grams of penicillin V (1 gram for children under 60 lbs) 1 hour before the procedure, and then 1 gram (500 mg for children under 60 lbs) 6 hours later.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_293de7fb-db23-4696-ac75-1e5b82ed9b5e"></a><a name="section-9.1"></a><p></p>
<h2>Directions for preparing oral solution</h2>
<p class="First">Prepare solution at the time of dispensing by adding the water in two portions to the bottle as follows: Loosen powder by tapping the bottle, add about half the water, and shake well. Add the remaining water and shake well to complete solution. Each teaspoon (5 mL) will contain Penicillin V Potassium equivalent to 125 mg or 250 mg of Penicillin V.</p>
<table>
<colgroup>
<col width="33%">
<col width="33%">
<col width="33%">
</colgroup>
<tbody class="Headless">
<tr class="First Toprule">
<td valign="top"><p class="First"><span class="Bold"><span class="Underline">Product</span></span></p></td>
<td valign="top">
<p class="First"><span class="Bold"><span class="Underline">Bottle</span></span></p>
<p><span class="Bold"><span class="Underline"> Size</span></span></p>
</td>
<td valign="top">
<p class="First"><span class="Bold"><span class="Underline">Amount of water</span></span></p>
<p><span class="Bold"><span class="Underline"> required for</span></span></p>
<p><span class="Bold"><span class="Underline"> reconstitution</span></span></p>
</td>
</tr>
<tr>
<td valign="top"><p class="First">125 mg/5 mL</p></td>
<td valign="top"><p class="First">100 mL</p></td>
<td valign="top"><p class="First">65 mL</p></td>
</tr>
<tr>
<td valign="top"></td>
<td valign="top"><p class="First">200 mL</p></td>
<td valign="top"><p class="First">127 mL</p></td>
</tr>
<tr>
<td valign="top"><p class="First">250 mg/5 mL</p></td>
<td valign="top"><p class="First">100 mL</p></td>
<td valign="top"><p class="First">65 mL</p></td>
</tr>
<tr class="Botrule Last">
<td valign="top"></td>
<td valign="top"><p class="First">200 mL</p></td>
<td valign="top"><p class="First">127 mL</p></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Note: Shake the oral solution well before using.</span></p>
<p>Store the reconstituted solution in a refrigerator. Discard any unused portion after 14 days. Keep the bottle tightly closed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_b0652b10-738d-481e-bf6f-5f349e8fd648"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Penicillin V Potassium Tablets, USP 250 mg (400,000 units) - White, oval, biconvex tablets engraved S20.</p>
<p>NDC 67253-200-10 Bottles of 100<br>NDC 67253-200-11 Bottles of 1,000</p>
<p>Penicillin V Potassium Tablets, USP 500 mg (800,000 units) -White, oval, biconvex tablets engraved S21.</p>
<p>NDC 67253-201-10 Bottles of 100<br>NDC 67253-201-50 Bottles of 500<br>NDC 67253-201-11 Bottles of 1,000</p>
<p>Store at 20Â° to 25Â°C (68Â° to 77Â°F). [See USP Controlled Room Temperature]. Keep tightly closed. Protect from moisture.</p>
<p>Penicillin V Potassium for Oral Solution, USP, is available as a powder which when reconstituted as directed yields a red color, fruit-flavored solution.</p>
<p>NDC 67253-202-10 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 125 mg/5 mL-<br>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 100 mL individual bottles<br>NDC 67253-202-20Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 125 mg/5 mL-<br>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 200 mL individual bottles</p>
<p>When reconstituted according to the directions, each 5 mL contains Penicillin V Potassium equivalent to 125 mg (200,000 units) of Penicillin V.</p>
<p>NDC 67253-203-10 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 250 mg/5 mL-<br>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 100 ml individual bottles<br>NDC 67253-203-20 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 250 mg/5 mL-<br>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 200 mL individual bottles</p>
<p>When reconstituted according to the directions, each 5 mL contains Penicillin V Potassium equivalent to 250 mg (400,000 units) of Penicillin V.</p>
<p>Store the dry powder at 20Â° to 25Â°C (68 to 77Â°F). [See USP Controlled Room Temperature]. Protect from moisture.  Keep bottle tightly closed. After reconstitution: Store in a refrigerator. Discard unused portion after 14 days.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="i4i_references_id_e32d9bfc-fce5-417e-a92b-b1c82c34774f"></a><a name="section-11"></a><p></p>
<h1>REFERENCES</h1>
<dl>
<dt>1.</dt>
<dd>American Heart Association, 1984. Prevention of <span class="product-label-link" type="condition" conceptid="4116649" conceptname="Bacterial endocarditis">bacterial endocarditis</span>. Circulation 70(6): 1123Aâ€“1127A.</dd>
<dt>2.</dt>
<dd>Clinical and Laboratory Standards Institute. <span class="Italics">Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard-Eleventh Edition. </span>CLSI document M02-A11. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012.</dd>
<dt>3.</dt>
<dd>Clinical and Laboratory Standards Institute. <span class="Italics">Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically; Approved Standard-Ninth Edition. </span>CLSI document M07-A9. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012.</dd>
<dt>4.</dt>
<dd>Clinical and Laboratory Standards Institute. <span class="Italics">Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. </span>CLSI document M100-S22. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012.</dd>
</dl>
<p class="First"><br><br>Manufactured for:<br><span class="Bold">DAVA Pharmaceuticals, Inc.</span><br>Fort Lee, NJ 07024, USA<br><br>by:<br><span class="Bold">Suir Pharma Ireland Ltd.</span><br>Clonmel, Ireland.</p>
<p>Rev. 03/2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L45de61f3-981a-469a-9e5f-b8903b90c5fa"></a><a name="section-12"></a><p></p>
<h1>Image of 250mg label</h1>
<p class="First"><img alt="image of 250mg label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e3b6a3b4-a61a-4432-9e90-c1ba9e210939&amp;name=20140923091328233_0001.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PENICILLIN V POTASSIUMÂ 		
					</strong><br><span class="contentTableReg">penicillin v potassium tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:49999-002(NDC:67253-200)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PENICILLIN V POTASSIUM</strong> (PENICILLIN V) </td>
<td class="formItem">PENICILLIN V</td>
<td class="formItem">250Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOLS</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL</td>
<td class="formLabel">Size</td>
<td class="formItem">14mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">S20</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:49999-002-28</td>
<td class="formItem">28  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:49999-002-30</td>
<td class="formItem">30  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:49999-002-40</td>
<td class="formItem">40  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA062936</td>
<td class="formItem">02/01/2004</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Lake Erie Medical DBA Quality Care Products LLC
							(831276758)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Lake Erie Medical &amp; Surgical Supply DBA Quality Care Products LLC</td>
<td class="formItem"></td>
<td class="formItem">092172824</td>
<td class="formItem">relabel(49999-002)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>d83e501b-3a28-420b-8328-b72d457d765f</div>
<div>Set id: e3b6a3b4-a61a-4432-9e90-c1ba9e210939</div>
<div>Version: 1</div>
<div>Effective Time: 20140926</div>
</div>
</div>Â <div class="DistributorName">Lake Erie Medical DBA Quality Care Products LLC</div></p>
</body></html>
